Successful management of acute thromboembolic disease complicated with heparin induced thrombocytopenia type II (HIT II): a case series
Open Access
- 1 January 2008
- journal article
- Published by Springer Nature in Thrombosis Journal
- Vol. 6 (1) , 9
Abstract
Heparin-induced thrombocytopenia type II (HIT II) is a rare immune-mediated complication of heparin. The diagnosis of HIT is considered in patients exposed to heparin, presenting with thrombocytopenia and thrombosis.Keywords
This publication has 22 references indexed in Scilit:
- How Frequently Is Venous Thromboembolism in Heparin-Treated Patients Associated With Heparin-Induced Thrombocytopenia?Chest, 2006
- The management of heparin‐induced thrombocytopeniaBritish Journal of Haematology, 2006
- New Concepts in Heparin-Induced Thrombocytopenia: Diagnosis and ManagementJournal of Thrombosis and Thrombolysis, 2006
- Fondaparinux: A potential new therapy for HITHematology, 2005
- The Management of Patients With Heparin-Induced Thrombocytopenia Who Require Anticoagulant TherapyChest, 2005
- Heparin-Induced Thrombocytopenia: Recognition, Treatment, and PreventionChest, 2004
- HIT/HITT and alternative anticoagulation: current conceptsBritish Journal of Anaesthesia, 2003
- Heparin-induced thrombocytopenia: an overviewBlood Reviews, 2002
- Failure of early heparin cessation as treatment for heparin-induced thrombocytopeniaThe American Journal of Medicine, 1999
- Heparin-induced thrombocytopenia with thrombosis: Incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institutionAmerican Journal of Hematology, 1997